We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Key Protein in Activating Cell Death Is Identified

By Biotechdaily staff writers
Posted on 05 Jul 2004
A key protein that is an integral component of the pathway leading to programmed cell death has been identified, which may lead to implications for regulating cell death and as well as the development of new treatments for some cancers and autoimmune diseases.

The new finding builds on previous research by Dr. More...
Doug Green, Ph.D. and a team of scientists at La Jolla Institute for Allergy & Immunology (San Diego, CA, USA), where Dr. Green and his team found that the mitochondria triggers the proteins called caspases to kill the cell. In the current study, the scientists found that the caspases accomplish this by going back into the mitochondria and destroying one key protein (NDUSF1), which in turn accelerates the destruction of the entire cell.

"This is one of the key steps for efficient dismantling of the cell,” said Dr. Green. "We feel that this event in the dying cell is part of the message which tells the immune system whether to create an immune response or not.”

Although it sounds contradictory, cell death is key to life. Programmed cell death is necessary to maintain health as unneeded or unhealthy cells in the body are killed off to leave room for what is vital. Cancer occurs when cells reproduce out of control and lose the capacity to undergo programmed cell death. The new research was published in the June 11, 2004, issue of Cell.

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
All-in-One Molecular System
AIO M160
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.